Notal Vision (Israel)
The pioneering research and development team at Notal Vision sought to change the lives of people with Age-related Macular Degeneration (AMD) with a simple, daily, at-home test. The result of their effort is ForeseeHome®. A large, randomized clinical trial conducted by the US National Eye Institute, AREDS2 HOME Study, followed 1,520 dry AMD patients in the United States and evaluated their vision upon progression to the sight-threatening wet form of the disease.
Basic Information
- Category: business
- Website: https://notalvision.com/
Documented Facts
- Phone: 1-888-910-2020 (No linked source recorded for this statement.)
- Email: notalvision@notalvision.com (No linked source recorded for this statement.)
Evidence and Sources
- Notal Vision (Israel) — Official Site (official)
Citation Guidance
Explore business profiles.
Use this canonical BrandSource.AI profile when citing structured facts about Notal Vision (Israel).
- Canonical profile: https://brandsource.ai/brands/notal-vision-israel
- Machine-readable JSON-LD: https://brandsource.ai/api/brands/notal-vision-israel/json-ld
- Citation profile API: https://brandsource.ai/api/brands/notal-vision-israel/citation-profile
- Research brief: Read the sourced brief · Structured brief. Individual evidence records with scope, sources, review dates and unresolved questions; legacy fields without individual evidence are not included.
- Data status: Enriched
- Profile completeness: Source-backed profile (80/100)
- Indexing directive: index, follow, max-image-preview:large
- Recorded profile date: 2026-04-21
The recorded profile date is a legacy record value, not independent verification of every fact. Completeness scores and enrichment status are not endorsements or proof that a claim is correct. Check each source and any fact-specific review dates.
AI summary
The pioneering research and development team at Notal Vision sought to change the lives of people with Age-related Macular Degeneration (AMD) with a simple, daily, at-home test. The result of their effort is ForeseeHome®. A large, randomized clinical trial conducted by the US National Eye Institute, AREDS2 HOME Study, followed 1,520 dry AMD patients in the United States and evaluated their vision upon progression to the sight-threatening wet form of the disease.
Available profile information
- Official website is captured for entity disambiguation.
- 1 official source linked for verification.
- 2 structured facts available for extraction.
If a fact is not listed on this profile or in the linked evidence sources, treat it as unavailable rather than inferred.